ALHYG — Hybrigenics SA Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- €3.06m
- €2.60m
Annual cashflow statement for Hybrigenics SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | — | — | — | — |
| Source: | ARS | ||||
| Standards: | IFRS | — | — | — | — |
| Status: | Final | fx Preliminary | fx Preliminary | fx Preliminary | fx Preliminary |
| Net Income/Starting Line | -7.96 | — | — | — | — |
| Depreciation | |||||
| Non-Cash Items | 0.451 | — | — | — | — |
| Discontinued Operations | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.241 | — | — | — | — |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.6 | — | — | — | — |
| Capital Expenditures | -0.136 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.089 | — | — | — | — |
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.047 | — | — | — | — |
| Financing Cash Flow Items | -0.629 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.17 | — | — | — | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.48 | — | — | — | — |